Mustang Bio Inc (NAS:MBIO)
$ 0.19 -0.01 (-5%) Market Cap: 9.08 Mil Enterprise Value: 6.54 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 37/100

Mustang Bio Inc at HC Wainwright Immune Cell Engager Virtual Conference Transcript

Aug 17, 2023 / 07:00PM GMT
Release Date Price: $3.26 (-10.44%)
Joe Pantginis
H.C. Wainwright & Co., LLC - Moderator

Okay, everybody. Welcome back to H.C. Wainwright's Immune Cell Engager Virtual Conference. My name is Joe Pantginis. I'm the Director of Research and Managing Director here at the firm and a real pleasure to have for a fireside chat Mustang Bio. I do cover the company with a buy rating. Presenting -- or as part of our discussion, I should say, for the fireside is Chief Executive Officer, Manny Litchman. Fantastic background, great years at Novartis, and really want to dive into the Mustang story here.

So thank you for being with us, Manny. So again, before we dive in a bit, I wanted to go a little high level with you and would love to get a bit of information regarding the forming of Mustang and what the company's focus is and overall looks to differentiate.

Questions & Answers

Manny Litchman
Mustang Bio, Inc. - President & CEO

Sure. Thanks so much, Joe, for the question, and thanks so much for the opportunity to present on behalf of Mustang Bio. So in terms of the question of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot